Clinical Trials
34 trialsNCT07144345 2026-04-22
Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Face and Scalp
Sun Pharmaceutical Industries Limited
Phase 3 Recruiting
NCT07144852 2026-04-22
Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Upper Extremities
Sun Pharmaceutical Industries Limited
Phase 3 Recruiting
NCT05923060 2026-02-20
Imaging Techniques to Monitor Photosensitizer and sO2 Levels During Photodynamic Therapy of Actinic Keratoses
Case Comprehensive Cancer Center
Phase 2 Completed
NCT07053852 2026-01-02
Activation of Ameluz With BBL HEROic for the Treatment of Actinic Keratoses and Photodamage
Rochester Dermatologic Surgery
Phase 1 Completed
NCT06027619 2025-10-23
Short Contact Protocols to Reduce Pain During 10% ALA Gel Red-light Photodynamic Therapy of Actinic Keratoses
Case Comprehensive Cancer Center
Phase 2 Completed
NCT03066843 2025-01-31
Photodynamic Therapy Incubation Times for Actinic Keratosis
Northwestern University
Phase NA Active not recruiting
NCT06745999 2024-12-24
Cryotherapy in Combination with Red Light PDT for Actinic Keratosis of Full Face
Psoriasis Treatment Center of Central New Jersey
Phase 4 Unknown
NCT03963102 2024-07-26
Duration of Ameluz Application in Acral Actinic Keratoses Response
Royal Cornwall Hospitals Trust
Phase 4 Terminated
NCT03327831 2024-06-27
Study of Daylight Photodynamic Therapy With Aminolevulinic Acid for Actinic Keratoses
University of California, Irvine
Phase 4 Completed
NCT01966120 2023-07-28
Safety and Efficacy Study for the Field-directed Treatment of Actinic Keratosis (AK) With Photodynamic Therapy (PDT)
Biofrontera Bioscience GmbH
Phase 3 Completed
NCT03322293 2022-03-09
Daylight Photodynamic Therapy for Actinic Keratosis
University of California, San Francisco
Phase 1 Completed
NCT02867722 2021-02-01
DaylightPDT
Brigham and Women's Hospital
Phase NA Withdrawn
NCT02464709 2019-08-28
Daylight PDT for Actinic Keratoses: a Multicentre Study Comparing Two Photosensitizers (BF-200 ALA Versus MAL)
Joint Authority for Päijät-Häme Social and Health Care
Phase 4 Completed
NCT03642535 2019-03-19
Aminolevulinic Acid-photodynamic Therapy for Facial Actinic Keratosis Treatment and Prevention
Shanghai Dermatology Hospital
Phase 4 Unknown
NCT02594644 2018-11-29
The Use of Microneedles to Expedite Treatment Time in Photodynamic Therapy
University of California, Davis
Phase NA Completed
NCT02239679 2018-08-24
Controlled Study of the Occurrence of Actinic Keratosis on the Face After Cryotherapy + Aminolevulinic Acid (ALA) Photodynamic Therapy
DUSA Pharmaceuticals, Inc.
Phase 2 Completed
NCT02632110 2018-01-18
Microneedle Lesion Preparation Prior to Aminolevulinic Acid Photodynamic Therapy (ALA-PDT) for AK on Face
DUSA Pharmaceuticals, Inc.
Phase 2 Completed
NCT03024060 2017-11-07
Phase 3 Study of Levulan With New Blue Light for AK on the Face or Scalp
DUSA Pharmaceuticals, Inc.
Phase 3 Withdrawn
NCT02628236 2017-09-18
Maximal Use Systemic Exposure Study of Levulan Kerastick (MUSE 2)
DUSA Pharmaceuticals, Inc.
Phase 2 Completed
NCT02622594 2017-07-19
Bilateral Comparison of Treatment of Facial Actinic Keratoses Using Microneedling and Photodynamic Therapy With Aminolevulinic Acid and Blue Light Versus Photodynamic Therapy With Aminolevulinic Acid and Blue Light Using Two Incubation Times
Dermatology, Laser & Vein Specialists of the Carolinas
Phase 4 Completed
NCT01812837 2017-06-15
The Use of Microneedles in Photodynamic Therapy
University of California, Davis
Phase NA Completed
NCT00524485 2017-06-14
Photodynamic Therapy Using Topical Aminolevulinic Acid in Treating Patients With Actinic Keratosis
Roswell Park Cancer Institute
Phase NA Terminated
NCT02799069 2017-04-28
Evaluation of Safety and Efficacy of BF-200 ALA for the Treatment of Actinic Keratosis With Photodynamic Therapy
Biofrontera Bioscience GmbH
Phase 3 Completed
NCT02799082 2017-04-06
Evaluation of Efficacy and Safety of BF-200 ALA Used With Photodynamic Therapy in Patients With Actinic Keratosis.
Biofrontera Bioscience GmbH
Phase 3 Completed
NCT02281136 2017-01-13
Maximal Use Systemic Exposure (MUSE) Study of Levulan Kerastick
DUSA Pharmaceuticals, Inc.
Phase 2 Completed
NCT01475955 2016-10-28
Short-incubation Levulan Photodynamic Therapy Versus Vehicle for Face/Scalp Actinic Keratosis (AK)
DUSA Pharmaceuticals, Inc.
Phase 2 Completed
NCT02209012 2016-09-23
Twelve Month Follow-Up of CP0108
DUSA Pharmaceuticals, Inc.
Completed
NCT02799030 2016-07-19
A Clinical Trial of Topical Photodynamic Therapy With 5-aminolevulinic Acid for the Treatment of Actinic Keratosis
Biofrontera Bioscience GmbH
Phase 2 Completed
NCT02647151 2016-01-06
Efficacy and Safety of Treatment of Actinic Keratoses With Photodynamic Therapy Between MAL Cream and ALA Gel
Fundación Instituto Valenciano de OncologÃa
Phase 4 Unknown
NCT02137785 2015-09-16
Safety and Efficacy Study of Photodynamic Therapy With Levulan Kerastick + Blue Light for Actinic Keratoses on the Upper Extremities
DUSA Pharmaceuticals, Inc.
Phase 3 Completed
NCT01203878 2014-12-08
Treatment of Actinic Keratoses of the Face With Imiquimod 3.75% Cream Followed by Photodynamic Therapy
Tennessee Clinical Research Center
Phase 4 Terminated
NCT00002975 2013-10-10
Photodynamic Therapy in Treating Patients With Skin Cancer
Roswell Park Cancer Institute
Phase 2 Completed
NCT01458587 2013-03-14
Levulan PDT Versus Vehicle for Extremity Actinic Keratoses (AK)
DUSA Pharmaceuticals, Inc.
Phase 2 Completed
NCT00865878 2011-10-21
ALA-PDT Versus Vehicle PDT for Treatment of AK and Reduction of New NMSC in Solid Organ Transplant Recipients
DUSA Pharmaceuticals, Inc.
Phase 2 Terminated